-
Je něco špatně v tomto záznamu ?
Ze světové literatury
Status neindexováno Jazyk čeština Země Česko
Typ dokumentu zprávy
J Bone Miner Res. 2011 Dec;26(12):2804-2811. Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover / van Lierop AH, Hamdy NA, Hamersma H, van Bezooijen RL, Power J, Loveridge N, Papapoulos SE -- J Nutr Biochem 2012 Jan;23(1):60-68. Dietary supplementation with dried plum prevents ovariectomy-induced bone loss while modulating the immunne response in C57BL/6J mice / Rendina E, Lim YF, Marlow D, Wang Y, Clarke SL, Kuvibidila S, Lucas EA, Smith BJ -- J Clin Endocrinol Metab. 2012 Jan;97(1):286-292. Low-Dose Zoledronate in Osteopenic Postmenopausal Women: A Randomized Controlled Trial / Grey A, Bolland M, Wong S, Horne A, Gamble G, Reid IR -- Clin Nephrol. 2012 Feb;77(2):97-104. Is transiliac bone biopsy a painful procedure? / Audran M, Maury E, Bouvard B, Legrand E, Baslé MF, Chappard D --J. Bone Miner Res. 2012 Marz;27(3):687-693. Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures / Austin M, Yang YC, Vittinghoff E, Adami S, Boonen S, Bauer DC, Bianchi G, Bolognese MA, Christiansen C, Eastell R, Grauer A, Hawkins F, Kendler DL, Oliveri B, McClung MR, Reid IR, Siris ES, Zanchetta J, Zerbini CA, Libanati C, Cummings SR -- Cancer, 2012 Mar1;118(5):1236-1243. Exposure to bisphosphonates and risk of colorectal cancer: A population-based nested case-control study / Singh H, Nugent Z, Demers A, Mahmud S, Bernstein C -- Bone. 2012 Mar;50(3):739-742. Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin / Gatti D, Viapiana O, Adami S, Idolazzi L, Fracassi E, Rossini M -- Menopause. 2012 Apr;19(4):456-460. Adolescent pregnancy is associated with osteoporosis in postmenopausal women. Cho GJ, Shin JH, Yi KW, Park HT, Kim T, Hur JY, Kim SH -- Nutrition. 2012 Apr;28(4): 344-356. A 21st century evaluation of the safety of oral vitamin D / Glade MJ -- Osteporos Int. 2012 Jul;23(7):2059-2062. Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis / Yilmaz M, Taninmis H, Kara E, Ozagari A, Unsal A -- J Bone Miner Metab. 2012 Sep;30(5):596-601. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures / Choe EY, Song JE, Park KH, Seok H, Lee EJ, Lim SK, Rhee Y -- Osteoporos Int. 2012 Oct;23(10):2461-2467. Skeletal and hormonal responses to vitamin D supplementation durign sunlight deprivation in Antarctic expeditioners / Iuliano-Burns S, Ayton J, Hillam S, Jones G, King K, Macleod S, Seeman E -- Eur J Nutr. 2012 Dec;51(8):939-945. Is a daily supplementation with 40 microgram vitamin D(3) sufficient? A randomised controlled trial / Toss G, Magnusson P
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13011340
- 003
- CZ-PrNML
- 005
- 20130524061729.0
- 007
- ta
- 008
- 130327s2012 xr f 000 0cze||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze
- 044 __
- $a xr
- 245 00
- $a Ze světové literatury
- 505 0_
- $a J Bone Miner Res. 2011 Dec;26(12):2804-2811. Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover / van Lierop AH, Hamdy NA, Hamersma H, van Bezooijen RL, Power J, Loveridge N, Papapoulos SE -- J Nutr Biochem 2012 Jan;23(1):60-68. Dietary supplementation with dried plum prevents ovariectomy-induced bone loss while modulating the immunne response in C57BL/6J mice / Rendina E, Lim YF, Marlow D, Wang Y, Clarke SL, Kuvibidila S, Lucas EA, Smith BJ -- J Clin Endocrinol Metab. 2012 Jan;97(1):286-292. Low-Dose Zoledronate in Osteopenic Postmenopausal Women: A Randomized Controlled Trial / Grey A, Bolland M, Wong S, Horne A, Gamble G, Reid IR -- Clin Nephrol. 2012 Feb;77(2):97-104. Is transiliac bone biopsy a painful procedure? / Audran M, Maury E, Bouvard B, Legrand E, Baslé MF, Chappard D --J. Bone Miner Res. 2012 Marz;27(3):687-693. Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures / Austin M, Yang YC, Vittinghoff E, Adami S, Boonen S, Bauer DC, Bianchi G, Bolognese MA, Christiansen C, Eastell R, Grauer A, Hawkins F, Kendler DL, Oliveri B, McClung MR, Reid IR, Siris ES, Zanchetta J, Zerbini CA, Libanati C, Cummings SR -- Cancer, 2012 Mar1;118(5):1236-1243. Exposure to bisphosphonates and risk of colorectal cancer: A population-based nested case-control study / Singh H, Nugent Z, Demers A, Mahmud S, Bernstein C -- Bone. 2012 Mar;50(3):739-742. Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin / Gatti D, Viapiana O, Adami S, Idolazzi L, Fracassi E, Rossini M -- Menopause. 2012 Apr;19(4):456-460. Adolescent pregnancy is associated with osteoporosis in postmenopausal women. Cho GJ, Shin JH, Yi KW, Park HT, Kim T, Hur JY, Kim SH -- Nutrition. 2012 Apr;28(4): 344-356. A 21st century evaluation of the safety of oral vitamin D / Glade MJ -- Osteporos Int. 2012 Jul;23(7):2059-2062. Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis / Yilmaz M, Taninmis H, Kara E, Ozagari A, Unsal A -- J Bone Miner Metab. 2012 Sep;30(5):596-601. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures / Choe EY, Song JE, Park KH, Seok H, Lee EJ, Lim SK, Rhee Y -- Osteoporos Int. 2012 Oct;23(10):2461-2467. Skeletal and hormonal responses to vitamin D supplementation durign sunlight deprivation in Antarctic expeditioners / Iuliano-Burns S, Ayton J, Hillam S, Jones G, King K, Macleod S, Seeman E -- Eur J Nutr. 2012 Dec;51(8):939-945. Is a daily supplementation with 40 microgram vitamin D(3) sufficient? A randomised controlled trial / Toss G, Magnusson P
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a zprávy $7 D016433
- 773 0_
- $t Osteologický bulletin $x 1211-3778 $g Roč. 17, č. 4 (2012), s. 160-163 $w MED00011060
- 856 41
- $u https://smos.cz/wp-content/uploads/2019/11/osteologicky_bulletin_2012_04.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4074 $c 474 a $y 3 $z 0
- 990 __
- $a 20130327121218 $b ABA008
- 991 __
- $a 20130524062644 $b ABA008
- 999 __
- $a ok $b bmc $g 974372 $s 809612
- BAS __
- $a 3
- BMC __
- $a 2012 $b 17 $c 4 $i 1211-3778 $m Osteologický bulletin $n Osteol. bull. $x MED00011060 $d 160-163
- LZP __
- $a NLK 2013-17/vtbi